These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 38984678)

  • 1. Value assessment and decision-making: how to move health systems forward?
    Wallenburg I; Friebel R
    Health Econ Policy Law; 2024 Apr; 19(2):151-152. PubMed ID: 38984678
    [No Abstract]   [Full Text] [Related]  

  • 2. One size does not always fit all in value assessment.
    Basu A; Grieve R; Pritchard D; Stevens W
    Am J Manag Care; 2019 Nov; 25(11):540-542. PubMed ID: 31747231
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ISPOR's Initiative on US Value Assessment Frameworks: The Use of Cost-Effectiveness Research in Decision Making among US Insurers.
    Solow B; Pezalla EJ
    Value Health; 2018 Feb; 21(2):166-168. PubMed ID: 29477395
    [No Abstract]   [Full Text] [Related]  

  • 4. Patient-centered performance management: enhancing value for patients and health care systems.
    Kerr EA; Hayward RA
    JAMA; 2013 Jul; 310(2):137-8. PubMed ID: 23839743
    [No Abstract]   [Full Text] [Related]  

  • 5. [Cost-effectiveness alone is not sufficient as basis for prioritization].
    Laine J
    Duodecim; 2014; 130(20):2094-8. PubMed ID: 25558607
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Health Economics Approach to US Value Frameworks: Serving the Needs of Decision Making.
    Norman R; Chalkidou K; Culyer AJ
    Value Health; 2018 Feb; 21(2):117-118. PubMed ID: 29477387
    [No Abstract]   [Full Text] [Related]  

  • 7. The role of cost-consequence analysis in healthcare decision-making.
    Mauskopf JA; Paul JE; Grant DM; Stergachis A
    Pharmacoeconomics; 1998 Mar; 13(3):277-88. PubMed ID: 10178653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Decision analytic modeling and their impact on health care decision making].
    Inotai A; Kaló Z; Mészáros A
    Acta Pharm Hung; 2009; 79(2):63-9. PubMed ID: 19634636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical Decision Support Systems.
    McCartney PR
    MCN Am J Matern Child Nurs; 2007; 32(1):58. PubMed ID: 17308462
    [No Abstract]   [Full Text] [Related]  

  • 10. The Need for an Improved Evidence Base to Inform the Health Care Decision-making Process-Reply.
    Tarride JE; Paterson JM; Anvari M
    JAMA Surg; 2021 Apr; 156(4):399-400. PubMed ID: 33471049
    [No Abstract]   [Full Text] [Related]  

  • 11. The priceless value of human life.
    Crum GE; Rice DP; Hodgson TA
    Am J Public Health; 1982 Nov; 72(11):1299-300. PubMed ID: 11643809
    [No Abstract]   [Full Text] [Related]  

  • 12. Economic appraisal and health service decision making.
    Drummond MF
    Eff Health Care; 1983 Jun; 1(1):25-33. PubMed ID: 10310174
    [No Abstract]   [Full Text] [Related]  

  • 13. ISPOR's Initiative on US Value Assessment Frameworks: An Industry Perspective.
    Burkholder R; Dougherty JS; Neves LA
    Value Health; 2018 Feb; 21(2):173-175. PubMed ID: 29477398
    [No Abstract]   [Full Text] [Related]  

  • 14. An Overview of Value, Perspective, and Decision Context-A Health Economics Approach: An ISPOR Special Task Force Report [2].
    Garrison LP; Pauly MV; Willke RJ; Neumann PJ
    Value Health; 2018 Feb; 21(2):124-130. PubMed ID: 29477389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Response to a commentary by Barr (2022) on Edoka and Stacey (2020) estimating a cost-effectiveness threshold for healthcare decision-making in South Africa.
    Edoka I; Stacey N
    Health Policy Plan; 2022 Sep; 37(8):1070-1073. PubMed ID: 35762464
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ISPOR's Initiative on US Value Assessment Frameworks: Seeking a Role for Health Economics.
    Sculpher M
    Value Health; 2018 Feb; 21(2):171-172. PubMed ID: 29477397
    [No Abstract]   [Full Text] [Related]  

  • 17. A Health Economics Approach to US Value Assessment Frameworks-Summary and Recommendations of the ISPOR Special Task Force Report [7].
    Garrison LP; Neumann PJ; Willke RJ; Basu A; Danzon PM; Doshi JA; Drummond MF; Lakdawalla DN; Pauly MV; Phelps CE; Ramsey SD; Towse A; Weinstein MC
    Value Health; 2018 Feb; 21(2):161-165. PubMed ID: 29477394
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decision theory and health resource allocations.
    Hoppe RB
    Theor Med; 1983 Jun; 4(2):193-205. PubMed ID: 11650581
    [No Abstract]   [Full Text] [Related]  

  • 19. Cost-utility analysis: use QALYs only with great caution.
    McGregor M
    CMAJ; 2003 Feb; 168(4):433-4. PubMed ID: 12591784
    [No Abstract]   [Full Text] [Related]  

  • 20. ISPOR's Initiative on US Value Assessment Frameworks: A Missed Opportunity for ISPOR and Patients.
    Perfetto EM
    Value Health; 2018 Feb; 21(2):169-170. PubMed ID: 29477396
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.